Brain DOPA-5-HTP decarboxylase activity after the chronic administration of L-dopa or 5-hydroxy-L-tryptophan in normal and lesioned cats.
D006916:5-Hydroxytryptophan / Q000494:pharmacology*; D000818:Animals; D001679:Biogenic Amines / Q000378:metabolism*; D001921:Brain / Q000378:metabolism*; D001923:Brain Chemistry; D002415:Cats; D002540:Cerebral Cortex / Q000378:metabolism; D003342:Corpus Striatum / Q000201:enzymology / Q000378:metabolism / Q000502:physiology*; D004295:Dihydroxyphenylalanine / Q000494:pharmacology*; D004296:Dopa Decarboxylase / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D005260:Female; D007031:Hypothalamus / Q000378:metabolism; D008297:Male; D008636:Mesencephalon / Q000378:metabolism; D009434:Neural Pathways / Q000502:physiology; D009638:Norepinephrine / Q000378:metabolism; D012701:Serotonin / Q000378:metabolism; D013378:Substantia Nigra / Q000502:physiology*; D013997:Time Factors
D001679:Biogenic Amines; D012701:Serotonin; D004295:Dihydroxyphenylalanine; D006916:5-Hydroxytryptophan; D004296:Dopa Decarboxylase; D004298:Dopamine; D009638:Norepinephrine